BioSpace News Archive

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), today announced the closing of its upsized public offering of 2,927,267 American Depositary Shares (“ADSs”), which includes the full exercise of the underwriters’ option to purchase 381,817 additional ADSs, at a public offering price of $13.75 per ADS, for total gross proceeds of approximately $40.25 million,

Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced that Dan Chevallard, Chief Financial Officer of Viracta, will present a company overview at the 2020 BIO CEO and Investor Conference on Tuesday, February 11, 2020 at 2:30 pm ET in New York, NY.

At present, there is an outbreak of SARS virus called novel coronavirus 2020 going in China.

In a move to strengthen its position as a premier SaaS Practice Management & Complete Ambulatory EHR solution, PracticeSuite has announced a strategic partnership with the pioneering medical revenue cycle management experts behind Claimocity, an AI-driven cloud-based billing, scheduling, coding, credentialing, and mobile practice management solution exclusively for hospitalists.

Reflecting his commitment to offer the most state-of-the-art technologies to his patients, Jacob D. Steiger, M.D., Facial Plastic Surgeon, of Steiger Facial Plastic Surgery in Boca Raton is one of the first physicians nationally to have Sofwave ultrasound, the newest technology to hit the market to improve fine lines and wrinkles on the face and neck.

AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced its participation in the 22nd Annual BIO CEO & Investor Conference, taking place February 10-11, 2020 in New York City, having won the Buzz of BIO contest in the private company category.

Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left Ventricular Assist System (FILVAS).

Digipath, Inc. (OTCQB: DIGP), is pleased to announce a 50% increase in cannabis sample processing for January of 2020 versus the same period in 2019.

Carestream Health was awarded 37 new patents in 2019 by the U.S. Patent and Trademark Office for advances in digital radiography, mobile imaging X-ray systems and other healthcare technology areas.

TORONTO, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing for gross proceeds of CAD $500,000 (the “Offering”).